Thursday - January 22, 2026
Understanding GLP-1 Drugs: Cost, Safety, and Access in Context
January 20, 2026
WASHINGTON, Jan. 20 -- The National Academy of Medicine issued the following news:

* * *

Understanding GLP-1 Drugs: Cost, Safety, and Access in Context

*

Experts from UT Southwestern, University of Colorado, Cato Institute, and Obesity Action Coalition share what evidence currently shows about GLP-1 function and effectiveness and discuss how to ensure patient access, affordability, and safety.

GLP-1 receptor agonists (GLP-1s)-bet . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products